1. Are Eating Disorders Risk Factors for Type 2 Diabetes? A Systematic Review and Meta-analysis

   • Ramfis Nieto-Martínez
   • Juan P. González-Rivas
   • Hermes Florez

   Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (B Conway and H Keenan, Section Editors) 22 November 2017 Article: 138

   

2. Cardiometabolic Risk in PCOS: More than a Reproductive Disorder

   • Laura C. Torchen

   Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors) 11 November 2017 Article: 137

   

3. Alcohol Consumption, Diabetes Risk, and Cardiovascular Disease Within Diabetes

   • Sarit Polsky
   • Halis K. Akturk

   Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (B Conway and H Keenan, Section Editors) 04 November 2017 Article: 136

   

4. A Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction

   • Jordi Merino
   • Miriam S. Udler
   • James B. Meigs

   Genetics (AP Morris, Section Editor) 04 November 2017 Article: 135

   

5. Modifiable Risk Factors for Cardiovascular Disease in Children with Type 1 Diabetes: Can Early Intervention Prevent Future Cardiovascular Events?

   • Evgenia Gourgari
   • Dana Dabelea
   • Kristina Rother

   Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors) Open access 03 November 2017 Article: 134

6. Hypoglycemia Reduction Strategies in the ICU

   • Susan Shapiro Braithwaite
   • Dharmesh B. Bavda
   • Oluwakemi T. Soetan

   Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors) 02 November 2017 Article: 133

7. Persistent Organic Pollutants as Risk Factors for Obesity and Diabetes

   • Chunxue Yang
   • Alice Pik Shan Kong
   • Arthur C.K. Chung

   Diabetes Epidemiology (NM Maruthur, Section Editor) 02 November 2017 Article: 132

   

8. Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls

   • Ulrik Pedersen-Bjergaard
   • Birger Thorsteinsson

   Therapies and New Technologies in the Treatment of Type 1 Diabetes (M Pietropaolo, Section Editor) 28 October 2017 Article: 131

   

9. Autoimmune Responses to Exosomes and Candidate Antigens Contribute to Type 1 Diabetes in Non-Obese Diabetic Mice

   • Yang D. Dai
   • Huiming Sheng
   • Kristi Marquardt

   Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor) 28 October 2017 Article: 130

   

10. Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis

    • Maria J. Redondo
    • Richard A. Oram
    • Andrea K. Steck

    Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor) 28 October 2017 Article: 129

11. Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?

    • Magnus F. Grøndahl
    • Damien J. Keating
    • Filip K. Knop

    Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors) 28 October 2017 Article: 128

12. Treatment-Induced Neuropathy of Diabetes

    • Christopher H. Gibbons

    Microvascular Complications—Neuropathy (R Pop-Busui, Section Editor) 24 October 2017 Article: 127

    

13. Understanding Cultural Influences on Dietary Habits in Asian, Middle Eastern, and Latino Patients with Type 2 Diabetes: A Review of Current Literature and Future Directions

    • Natalie Mora
    • Sherita Hill Golden

    Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (B Conway and H Keenan, Section Editors) 23 October 2017 Article: 126

14. Cardiorespiratory Fitness and Cardiac Autonomic Function in Diabetes

    • Martin Röhling
    • Alexander Strom
    • Dan Ziegler

    Microvascular Complications—Neuropathy (R Pop-Busui, Section Editor) 23 October 2017 Article: 125

    

15. The Infamous, Famous Sulfonylureas and Cardiovascular Safety: Much Ado About Nothing?

    • Laurentiu M. Pop
    • Ildiko Lingvay

    Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors) 23 October 2017 Article: 124

    

16. Health Benefits of Fasting and Caloric Restriction

    • Saeid Golbidi
    • Andreas Daiber
    • Ismail Laher

    Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (B Conway and H Keenan, Section Editors) 23 October 2017 Article: 123

    

17. Disentangling the Role of Melatonin and its Receptor MTNR1B in Type 2 Diabetes: Still a Long Way to Go?

    • Amélie Bonnefond
    • Philippe Froguel

    Genetics (AP Morris, Section Editor) 23 October 2017 Article: 122

    

18. Glucometrics and Insulinometrics

    • Bithika M. Thompson
    • Curtiss B. Cook

    Health Care Delivery Systems and Implementation in Diabetes (ME McDonnell and AR Sadhu, Section Editors) 23 October 2017 Article: 121

    

19. Insulin and Its Cardiovascular Effects: What Is the Current Evidence?

    • Sahana Pai Dongerkery
    • Pamela R. Schroeder
    • Mansur E. Shomali

    Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors) 23 October 2017 Article: 120